|Drug Patent Number||Company||Drug Patent Title||Drug Patent Expiry||Activity Alert|
|These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.|
|US8470359||TOLMAR THERAP||Sustained release polymer|| |
(16 days from now)
Eligard Kit is owned by Tolmar Therap.
Eligard Kit contains Leuprolide Acetate.
Eligard Kit has a total of 1 drug patent out of which 0 drug patents have expired.
Eligard Kit was authorised for market use on 24 July, 2002.
Eligard Kit is available in powder;subcutaneous dosage forms.
Eligard Kit can be used as method of treating cancer.
The generics of Eligard Kit are possible to be released after 15 October, 2023.
Market Authorisation Date: 24 July, 2002
Treatment: Method of treating cancer
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic